Skip to contentA
Astrana Health, Inc.
A
ASTHAstrana Health, Inc. Q2 2026 · 10-Q
Revenue$972.52M$972.52M+48.5% vs Q2 2025 Net Income$19.74M$19.74M+109.5% vs Q2 2025 EPS Diluted$0.40$0.40+110.5% vs Q2 2025 Operating Income$34,322,000+68.7% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Astrana Health, Inc. · CIK 1083446 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$28,870,000−67.7% Margins · derivedOperating margin3.5%+0.4 pt vs Q2 2025
Net margin2.0%+0.6 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 10, 2026 · 41 d after period end